EXANE DERIVATIVES

Q3 2019 13F Holdings Report, Stock Holdings

Signature - Title
Corinne Fleck - head of Regulatory affairs and reportings.
Location
Paris, France
Holdings as of
September 30, 2019
Value $
$510M
Num holdings
621
Date filed
10/15/2019, 12:36 PM
Description
All US holdings of this investor are reported in this report. The Form 13F report requires disclosure of the manager that files the report, the name and class of the security, the CUSIP code, the number of shares as of the end of the calendar quarter for which the report is filed, and the total market value. The market value column should not be used as a substitute for Assets Under Management (AUM), as it does not include cash held in accounts.
Previous filing
Q2 2019 - Jul 12, 2019
Next filing
Q4 2019 - Jan 22, 2020
Options Holdings
Showing stock holdings, see here for options holdings
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2019 Q3 compared to 2019 Q2 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Corinne FLECK Head of Regulatory affairs and reportings Paris, France 10/15/2019